Listen to this story
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now0:00
0:00
Loading audio file, please wait.
Shares of Eli Lilly and Co. jumped more than 4 percent today after a Morgan Stanley analyst upgraded the stock to “equal weight” from “underweight.”
After opening at $53.16, the shares rose as high as $54.49; the stock traded near $54.10 early this afternoon.
Morgan Stanley broker Jami Rubin said Wall Street’s fears about Lilly having difficulty getting regulatory approval for its anti-blood clot drug prasugrel have been overblown compared with Lilly’s potential for near-term profit gains, according to news reports.
Please enable JavaScript to view this content.
Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.